Compare Hinge Health Inc. Class A Common Stock (HNGE) vs ON Holding AG (ONON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs ON Holding AG — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.47B), while ON Holding AG trades at $35.34 (market cap $11.86B). The key difference: ON Holding AG is the larger of the two by market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, ON Holding AG nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and ON Holding AG for 24 Days on average.
| HNGE | ONON | |
|---|---|---|
Market Cap | $8.47B | $11.86B |
Volume | 1,624,526 | 10,043,743 |
Sector | Health | Consumer Cyclical |
52-Week High | $105.14 | $50.63 |
52-Week Low | $31.17 | $26.76 |
Typical Hold Time | 0 Days | 24 Days |
Enterprise Value | $8.09B | $11.03B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
ONON trades at $35.49, up 0.4% on the day, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $42.26. The company has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $0.44 exceeding the $0.4203 forecast. Strong fundamentals include a 64.82% gross margin and 23.95% ROE, while recent news highlights a $1 billion share buyback plan and ambitious 2029 growth targets.
The outlook is positive, driven by earnings momentum, direct-to-consumer expansion, and shareholder returns, though risks include high valuation multiples and competitive pressures. Upside potential exists if the company executes on its long-term growth strategy, but investors should be mindful of market volatility and execution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About ON Holding AG
ON Holding AG is a Swiss sports company primarily known for its high-performance running shoes, apparel, and accessories under the 'On' brand. The company emphasizes a blend of high-end design, proprietary cloud technology (like CloudTec cushioning), and sustainability in its products. On has rapidly gained market share globally, appealing to both competitive athletes and general consumers in the performance and lifestyle footwear segments.
Read more on ONON →
